Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Haojiandan Medicine Research & Development is a specialized contract research organization (CRO) and biotechnology firm based in Guangzhou, China. Established in 2015, the company focuses on the synthesis of pharmaceutical impurities, reference standards, and high-end pharmaceutical intermediates. They provide critical support for drug R&D, particularly in the areas of chemical process optimization and generic drug consistency evaluation. Haojiandan serves a global clientele, offering custom synthesis and analytical services to accelerate the drug development lifecycle. The company is recognized for its technical expertise in complex small molecule synthesis and its contribution to pharmaceutical quality control. Their extensive catalog of reference standards supports pharmaceutical companies in meeting regulatory requirements for drug safety and efficacy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou Haojiandan Medicine Research & Development.